Web Content Management

PRODUCTS

  • This easy-to-use process analytical technology device offers in-line bioprocess analysis and control with no complex modeling. Measure multiple critical parameters across media, across processes, across mammalian cell lines, across scales.

    All In-line Gain, No Modeling Pain

    MAVERICK is powered by Raman spectroscopy and a purpose-built de novo model. The de novo model is explicitly built on media chemistries and device physics, not on empirical data. It automatically interprets the spectra and quantifies process parameters enabling simultaneous measurements of glucose, lactate, and total biomass. This is achieved without the costs, complexities, and risks associated with conventional Process Analytical Technology (PAT) methods. There is no need to grapple with complex empirical models, reagents, or unreliable auto-sampling systems to implement in-line bioprocess analysis.

  • Planning to launch a patient-centric decentralized clinical trial? Give your clinical trial patients an app that makes it easy to participate—from anywhere at any time.

    Simplify clinical trial participation with an integrated eCOA and ePRO solution

    TrialKit’s electronic clinical outcome assessment (eCOA) and electronic patient-reported outcomes (ePRO) platform integrates with all currently available wearables, mobile operating systems, and web applications. Whether you collect data in the clinic, with provisioned devices, or take a bring-your-own-device (BYOD) approach, you can count on seamless data sharing and efficient study execution.

  • Altasciences’ experienced team specializes in early-phase renal and hepatic impairment studies, delivering tailored clinical pharmacology trials that support your regulatory submissions.

  • Navigating the technical challenges of mAbs production and scalability

    Monoclonal antibodies (mAbs) offer promising immunotherapy treatments, targeting antigens and diseases. Manufacturing these complex therapies presents challenges in scaling up, cost, and consistency. Germfree’s expertise in tailored cleanroom solutions addresses these obstacles, ensuring sterility and seamless equipment integration. By providing advanced facilities for both small-scale clinical trials and larger-scale production, Germfree contributes to the successful development and commercialization of mAbs, ultimately improving patient outcomes and transforming healthcare landscapes.

  • Gain human-relevant insights with patient-derived assay-ready organoids.

WHITE PAPERS AND CASE STUDIES

NEWS